Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paolo Morelli

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Human Vaccines|July 10, 2009
Measuring public health officers' opinions on new vaccination programs by means of the WHO Vaccine Introduction GuidelinesFederico Marchetti, Paolo Morelli
Contemporary Clinical Trials Communications|December 7, 2020
Risk and mitigation actions for clinical trials during COVID-19 pandemic (RiMiCOPa)Antonella Bacchieri, Andrea Rossi, Paolo Morelli
American Journal of Clinical Dermatology|February 3, 2011
Efficacy and safety of the Betamethasone valerate 0.1% plaster in mild-to-moderate chronic plaque psoriasis: a randomized, parallel-group, active-controlled, phase III studyLuigi Naldi, Nikhil Yawalkar, Andrzej Kaszuba, et al.
Arzneimittel-Forschung|August 25, 2006
Effect of permeation enhancers on buccal absorptionSusi Burgalassi, Patrizia Chetoni, Laura Dini, et al.
Respirology (Carlton, Vic.)|June 29, 2019
Airway inflammatory profile is correlated with symptoms in stable COPD: A longitudinal proof-of-concept cohort studyMarco Contoli, Simonetta Baraldo, Valentina Conti, et al.
The New England Journal of Medicine|May 18, 2007
Rescue use of beclomethasone and albuterol in a single inhaler for mild asthmaAlberto Papi, Giorgio W Canonica, Piero Maestrelli, et al.
The European Respiratory Journal|October 7, 2017
Long-term effects of inhaled corticosteroids on sputum bacterial and viral loads in COPDMarco Contoli, Alessia Pauletti, Maria Rita Rossi, et al.
The Lancet. Respiratory Medicine|December 8, 2014
Regular versus as-needed budesonide and formoterol combination treatment for moderate asthma: a non-inferiority, randomised, double-blind clinical trialAlberto Papi, Brunilda Marku, Nicola Scichilone, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Human Vaccines|July 10, 2009
Measuring public health officers' opinions on new vaccination programs by means of the WHO Vaccine Introduction GuidelinesFederico Marchetti, Paolo Morelli
Contemporary Clinical Trials Communications|December 7, 2020
Risk and mitigation actions for clinical trials during COVID-19 pandemic (RiMiCOPa)Antonella Bacchieri, Andrea Rossi, Paolo Morelli
American Journal of Clinical Dermatology|February 3, 2011
Efficacy and safety of the Betamethasone valerate 0.1% plaster in mild-to-moderate chronic plaque psoriasis: a randomized, parallel-group, active-controlled, phase III studyLuigi Naldi, Nikhil Yawalkar, Andrzej Kaszuba, et al.
Arzneimittel-Forschung|August 25, 2006
Effect of permeation enhancers on buccal absorptionSusi Burgalassi, Patrizia Chetoni, Laura Dini, et al.
Respirology (Carlton, Vic.)|June 29, 2019
Airway inflammatory profile is correlated with symptoms in stable COPD: A longitudinal proof-of-concept cohort studyMarco Contoli, Simonetta Baraldo, Valentina Conti, et al.
The New England Journal of Medicine|May 18, 2007
Rescue use of beclomethasone and albuterol in a single inhaler for mild asthmaAlberto Papi, Giorgio W Canonica, Piero Maestrelli, et al.
The European Respiratory Journal|October 7, 2017
Long-term effects of inhaled corticosteroids on sputum bacterial and viral loads in COPDMarco Contoli, Alessia Pauletti, Maria Rita Rossi, et al.
The Lancet. Respiratory Medicine|December 8, 2014
Regular versus as-needed budesonide and formoterol combination treatment for moderate asthma: a non-inferiority, randomised, double-blind clinical trialAlberto Papi, Brunilda Marku, Nicola Scichilone, et al.
Pageof 1